All AbMole products are for research use only, cannot be used for human consumption.
Thiazolidinediones (TZDs), such as rosiglitazone (RSG) and pioglitazone, are antidiabetic drugs that improve glycemia by decreasing insulin resistance through the binding and activation of the peroxisome proliferator-activated receptor γ. Some TZDs might may also affect the activity of the γ isoform of PPAR. These receptors modulate the expression of genes involved in glucose and lipid metabolism, insulin signal transduction, inflammation and cell differentiation.
| Molecular Weight | 89.16 |
| Formula | C3H7NS |
| CAS Number | 504-78-9 |
| Solubility (25°C) | 10 mM in DMSO |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Related PPAR Products |
|---|
| WY 14643 (Pirinixic Acid)
WY 14643 (Pirinixic Acid) is a potent and selective, peroxisome proliferator-activated receptor-α (PPARα) agonist. |
| GSK 3787
GSK3787 is an orally available selective peroxisome proliferator-activated receptor δ (PPARδ) antagonist (pIC50 = 6.6). |
| Ciprofibrate
Ciprofibrate is a peroxisome proliferator-activated receptor α (PPARα) agonist. |
| ZLN005
ZLN005 is a novel and potent small molecule PGC-1α transcriptional activator. |
| Bezafibrate
Bezafibrate is the first clinically tested dual and pan-PPAR co-agonism. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
